Redeye: Tessin - Towards profitability
Redeye updates its estimates and base case after reviewing Tessin's Q2 report, which showed sales roughly in line with expectations. However, higher opex than anticipated resulted in slightly lower profitability than expected. Nevertheless, we believe the company is still on track to achieve profitability.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/